Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 242

1.

Comparing Expert and Non-Expert Assessment of Patients Presenting with Neurological Symptoms to the Emergency Department: A Retrospective Observational Study.

Hoyer C, Stein P, Ebert A, Rausch HW, Nagel S, Eisele P, Alonso A, Platten M, Szabo K.

Neuropsychiatr Dis Treat. 2020 Feb 13;16:447-456. doi: 10.2147/NDT.S236160. eCollection 2020.

2.

Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas.

Aslan K, Turco V, Blobner J, Sonner JK, Liuzzi AR, Núñez NG, De Feo D, Kickingereder P, Fischer M, Green E, Sadik A, Friedrich M, Sanghvi K, Kilian M, Cichon F, Wolf L, Jähne K, von Landenberg A, Bunse L, Sahm F, Schrimpf D, Meyer J, Alexander A, Brugnara G, Röth R, Pfleiderer K, Niesler B, von Deimling A, Opitz C, Breckwoldt MO, Heiland S, Bendszus M, Wick W, Becher B, Platten M.

Nat Commun. 2020 Feb 18;11(1):931. doi: 10.1038/s41467-020-14642-0.

3.

Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter-methylated malignant astrocytoma.

Wick A, Kessler T, Platten M, Meisner C, Bamberg M, Herrlinger U, Felsberg J, Weyerbrock A, Papsdorf K, Steinbach JP, Sabel M, Vesper J, Debus J, Meixensberger J, Ketter R, Hertler C, Mayer-Steinacker R, Weisang S, Bölting H, Reuss D, Reifenberger G, Sahm F, von Deimling A, Weller M, Wick W; NOA-08 Study Group of the Neurooncology Working Group (NOA) of the German Cancer Society.

Neuro Oncol. 2020 Feb 17. pii: noaa033. doi: 10.1093/neuonc/noaa033. [Epub ahead of print]

PMID:
32064499
4.

Validation of Rapid Magnetic Resonance Myelin Imaging in Multiple Sclerosis.

Ouellette R, Mangeat G, Polyak I, Warntjes M, Forslin Y, Bergendal Å, Plattén M, Uppman M, Treaba CA, Cohen-Adad J, Piehl F, Kristoffersen Wiberg M, Fredrikson S, Mainero C, Granberg T.

Ann Neurol. 2020 Feb 14. doi: 10.1002/ana.25705. [Epub ahead of print]

PMID:
32057118
5.

Monitoring innate immune cell dynamics in the glioma microenvironment by magnetic resonance imaging and multiphoton microscopy (MR-MPM).

Karimian-Jazi K, Münch P, Alexander A, Fischer M, Pfleiderer K, Piechutta M, Karreman MA, Solecki GM, Berghoff AS, Friedrich M, Deumelandt K, Kurz FT, Wick W, Heiland S, Bendszus M, Winkler F, Platten M, Breckwoldt MO.

Theranostics. 2020 Jan 1;10(4):1873-1883. doi: 10.7150/thno.38659. eCollection 2020.

6.

Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma.

Anssar TM, Leitzmann MF, Linker RA, Meier C, Becker C, Jick S, Sahm K, Platten M, Hau P, Seliger C.

Cancer Med. 2020 Feb;9(3):1263-1275. doi: 10.1002/cam4.2767. Epub 2019 Dec 10.

7.

The therapeutic potential of targeting tryptophan catabolism in cancer.

Opitz CA, Somarribas Patterson LF, Mohapatra SR, Dewi DL, Sadik A, Platten M, Trump S.

Br J Cancer. 2020 Jan;122(1):30-44. doi: 10.1038/s41416-019-0664-6. Epub 2019 Dec 10. Review.

PMID:
31819194
8.

cMyc and ERK activity are associated with resistance to ALK inhibitory treatment in glioblastoma.

Berberich A, Schmitt LM, Pusch S, Hielscher T, Rübmann P, Hucke N, Latzer P, Heßling B, Lemke D, Kessler T, Platten M, Wick W.

J Neurooncol. 2020 Jan;146(1):9-23. doi: 10.1007/s11060-019-03348-z. Epub 2019 Nov 28.

PMID:
31776900
9.

MRI-Based Manual versus Automated Corpus Callosum Volumetric Measurements in Multiple Sclerosis.

Platten M, Martola J, Fink K, Ouellette R, Piehl F, Granberg T.

J Neuroimaging. 2020 Mar;30(2):198-204. doi: 10.1111/jon.12676. Epub 2019 Nov 20.

PMID:
31750599
10.

TCR validation toward gene therapy for cancer.

Green EW, Bunse L, Bozza M, Sanghvi K, Platten M.

Methods Enzymol. 2019;629:419-441. doi: 10.1016/bs.mie.2019.10.010. Epub 2019 Nov 6.

PMID:
31727252
11.

High-throughput discovery of cancer-targeting TCRs.

Bunse L, Green EW, Platten M.

Methods Enzymol. 2019;629:401-417. doi: 10.1016/bs.mie.2019.10.009. Epub 2019 Nov 6.

PMID:
31727251
12.

Characterization of Contrast-Enhancing and Non-contrast-enhancing Multiple Sclerosis Lesions Using Susceptibility-Weighted Imaging.

Eisele P, Fischer K, Szabo K, Platten M, Gass A.

Front Neurol. 2019 Oct 18;10:1082. doi: 10.3389/fneur.2019.01082. eCollection 2019.

13.

Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities.

Reinhardt A, Stichel D, Schrimpf D, Koelsche C, Wefers AK, Ebrahimi A, Sievers P, Huang K, Casalini MB, Fernández-Klett F, Suwala A, Weller M, Gramatzki D, Felsberg J, Reifenberger G, Becker A, Hans VH, Prinz M, Staszewski O, Acker T, Dohmen H, Hartmann C, Paulus W, Heß K, Brokinkel B, Schittenhelm J, Buslei R, Deckert M, Mawrin C, Hewer E, Pohl U, Jaunmuktane Z, Brandner S, Unterberg A, Hänggi D, Platten M, Pfister SM, Wick W, Herold-Mende C, Korshunov A, Reuss DE, Sahm F, Jones DTW, Capper D, von Deimling A.

Acta Neuropathol Commun. 2019 Oct 28;7(1):163. doi: 10.1186/s40478-019-0801-8.

14.

Dietary tryptophan links encephalogenicity of autoreactive T cells with gut microbial ecology.

Sonner JK, Keil M, Falk-Paulsen M, Mishra N, Rehman A, Kramer M, Deumelandt K, Röwe J, Sanghvi K, Wolf L, von Landenberg A, Wolff H, Bharti R, Oezen I, Lanz TV, Wanke F, Tang Y, Brandao I, Mohapatra SR, Epping L, Grill A, Röth R, Niesler B, Meuth SG, Opitz CA, Okun JG, Reinhardt C, Kurschus FC, Wick W, Bode HB, Rosenstiel P, Platten M.

Nat Commun. 2019 Oct 25;10(1):4877. doi: 10.1038/s41467-019-12776-4.

15.

Driving mesenchymal transition in glioblastoma.

Platten M.

Neuro Oncol. 2020 Jan 11;22(1):1-2. doi: 10.1093/neuonc/noz195. No abstract available.

PMID:
31628483
16.

Uncompleted emergency department care and discharge against medical advice in patients with neurological complaints: a chart review.

Hoyer C, Stein P, Alonso A, Platten M, Szabo K.

BMC Emerg Med. 2019 Oct 11;19(1):52. doi: 10.1186/s12873-019-0273-y.

17.

Fulminant Cytotoxic Edema in a Patient with Pneumococcal Meningoencephalitis.

Alonso A, Etminan N, Krebs J, Szabo K, Platten M, Förster A.

J Clin Neurol. 2019 Oct;15(4):575-577. doi: 10.3988/jcn.2019.15.4.575. No abstract available.

18.

What remains after transient global amnesia (TGA)? An ultra-high field 7 T magnetic resonance imaging study of the hippocampus.

Paech D, Kuder TA, Roßmanith C, Griebe M, Eisele P, Platten M, Ladd ME, Schlemmer HP, Gass A, Szabo K.

Eur J Neurol. 2020 Feb;27(2):406-409. doi: 10.1111/ene.14099. Epub 2019 Oct 29.

PMID:
31573112
19.

Interaction between the heart and the brain in transient global amnesia.

Eisele P, Baumann S, Noor L, El-Battrawy I, Ebert A, Gass A, Akin I, Kittel M, Platten M, Szabo K.

J Neurol. 2019 Dec;266(12):3048-3057. doi: 10.1007/s00415-019-09529-0. Epub 2019 Sep 10.

PMID:
31506826
20.

Single-Cell High-Throughput Technologies in Cerebrospinal Fluid Research and Diagnostics.

Lanz TV, Pröbstel AK, Mildenberger I, Platten M, Schirmer L.

Front Immunol. 2019 Jun 11;10:1302. doi: 10.3389/fimmu.2019.01302. eCollection 2019. Review.

21.

Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma.

Shraibman B, Barnea E, Kadosh DM, Haimovich Y, Slobodin G, Rosner I, López-Larrea C, Hilf N, Kuttruff S, Song C, Britten C, Castle J, Kreiter S, Frenzel K, Tatagiba M, Tabatabai G, Dietrich PY, Dutoit V, Wick W, Platten M, Winkler F, von Deimling A, Kroep J, Sahuquillo J, Martinez-Ricarte F, Rodon J, Lassen U, Ottensmeier C, van der Burg SH, Thor Straten P, Poulsen HS, Ponsati B, Okada H, Rammensee HG, Sahin U, Singh H, Admon A.

Mol Cell Proteomics. 2019 Jun;18(6):1270. doi: 10.1074/mcp.W119.001571. No abstract available.

22.

Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.

Shraibman B, Barnea E, Kadosh DM, Haimovich Y, Slobodin G, Rosner I, López-Larrea C, Hilf N, Kuttruff S, Song C, Britten C, Castle J, Kreiter S, Frenzel K, Tatagiba M, Tabatabai G, Dietrich PY, Dutoit V, Wick W, Platten M, Winkler F, von Deimling A, Kroep J, Sahuquillo J, Martinez-Ricarte F, Rodon J, Lassen U, Ottensmeier C, van der Burg SH, Thor Straten P, Poulsen HS, Ponsati B, Okada H, Rammensee HG, Sahin U, Singh H, Admon A.

Mol Cell Proteomics. 2019 Jun;18(6):1255-1268. doi: 10.1074/mcp.RA119.001524.

PMID:
31154438
23.

Systematic Review and Meta-analysis of Treatment Interruptions in Human Immunodeficiency Virus (HIV) Type 1-infected Patients Receiving Antiretroviral Therapy: Implications for Future HIV Cure Trials.

Stecher M, Claßen A, Klein F, Lehmann C, Gruell H, Platten M, Wyen C, Behrens G, Fätkenheuer G, Vehreschild JJ.

Clin Infect Dis. 2020 Mar 17;70(7):1406-1417. doi: 10.1093/cid/ciz417.

PMID:
31102444
24.

[Treatment-associated neurological symptoms of cancer patients and their treatment].

Mildenberger I, Eisele P, Hofheinz R, Platten M.

Nervenarzt. 2019 Jun;90(6):587-593. doi: 10.1007/s00115-019-0712-8. Review. German.

PMID:
31089783
25.

Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study.

Nowosielski M, Gorlia T, Bromberg JEC, Sahm F, Harting I, Kickingereder P, Brandes AA, Taphoorn MJB, Taal W, Domont J, Idbaih A, Campone M, Clement PM, Weller M, Fabbro M, Le Rhun E, Platten M, Golfinopoulos V, van den Bent MJ, Bendszus M, Wick W.

Neurology. 2019 Jun 11;92(24):e2754-e2763. doi: 10.1212/WNL.0000000000007643. Epub 2019 May 10.

PMID:
31076534
26.

Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study.

Kickingereder P, Isensee F, Tursunova I, Petersen J, Neuberger U, Bonekamp D, Brugnara G, Schell M, Kessler T, Foltyn M, Harting I, Sahm F, Prager M, Nowosielski M, Wick A, Nolden M, Radbruch A, Debus J, Schlemmer HP, Heiland S, Platten M, von Deimling A, van den Bent MJ, Gorlia T, Wick W, Bendszus M, Maier-Hein KH.

Lancet Oncol. 2019 May;20(5):728-740. doi: 10.1016/S1470-2045(19)30098-1. Epub 2019 Apr 2.

PMID:
30952559
27.

How to integrate immunotherapy into standard of care in glioblastoma.

Platten M.

Neuro Oncol. 2019 Jun 10;21(6):699-700. doi: 10.1093/neuonc/noz043. No abstract available.

PMID:
30938444
28.

Correction to: Antiretroviral treatment indications and adherence to the German-Austrian treatment initiation guidelines in the German ClinSurv HIV Cohort between 1999 and 2016.

Stecher M, Schommers P, Schmidt D, Kollan C, Gunsenheimer-Bartmeyer B, Lehmann C, Platten M, Fätkenheuer G, Vehreschild JJ; ClinSurv Study Group.

Infection. 2019 Apr;47(2):257. doi: 10.1007/s15010-019-01281-x.

PMID:
30805900
29.

Susceptibility-weighted imaging in malignant melanoma brain metastasis.

Schwarz D, Niederle T, Münch P, Hielscher T, Hassel JC, Schlemmer HP, Platten M, Winkler F, Wick W, Heiland S, Delorme S, Bendszus M, Bäumer P, Breckwoldt MO.

J Magn Reson Imaging. 2019 Oct;50(4):1251-1259. doi: 10.1002/jmri.26692. Epub 2019 Feb 21.

PMID:
30793419
30.

Practice-changing developments in neuro-oncology: embracing heterogeneity.

Platten M.

Ther Adv Neurol Disord. 2019 Feb 8;12:1756286419827688. doi: 10.1177/1756286419827688. eCollection 2019. No abstract available.

31.

Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond.

Platten M, Nollen EAA, Röhrig UF, Fallarino F, Opitz CA.

Nat Rev Drug Discov. 2019 May;18(5):379-401. doi: 10.1038/s41573-019-0016-5. Review.

PMID:
30760888
32.

Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus.

Schiff D, Van den Bent M, Vogelbaum MA, Wick W, Miller CR, Taphoorn M, Pope W, Brown PD, Platten M, Jalali R, Armstrong T, Wen PY.

Neuro Oncol. 2019 Jul 11;21(7):837-853. doi: 10.1093/neuonc/noz033.

PMID:
30753579
33.

Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma.

Hilf N, Kuttruff-Coqui S, Frenzel K, Bukur V, Stevanović S, Gouttefangeas C, Platten M, Tabatabai G, Dutoit V, van der Burg SH, Straten PT, Martinez-Ricarte F, Ponsati B, Okada H, Lassen U, Admon A, Ottensmeier CH, Ulges A, Kreiter S, von Deimling A, Skardelly M, Migliorini D, Kroep JR, Idorn M, Rodon J, Piro J, Poulsen HS, Shraibman B, McCann K, Mendrzyk R, Lower M, Stieglbauer M, Britten CM, Capper D, Welters MJP, Sahuquillo J, Kiesel K, Derhovanessian E, Rusch E, Bunse L, Song C, Heesch S, Wagner C, Kemmer-Bruck A, Ludwig J, Castle JC, Schoor O, Tadmor AD, Green E, Fritsche J, Meyer M, Pawlowski N, Dorner S, Hoffgaard F, Rossler B, Maurer D, Weinschenk T, Reinhardt C, Huber C, Rammensee HG, Singh-Jasuja H, Sahin U, Dietrich PY, Wick W.

Nature. 2019 Feb;566(7745):E13. doi: 10.1038/s41586-019-0959-z.

PMID:
30733620
34.

Correlated MRI and Ultramicroscopy (MR-UM) of Brain Tumors Reveals Vast Heterogeneity of Tumor Infiltration and Neoangiogenesis in Preclinical Models and Human Disease.

Breckwoldt MO, Bode J, Sahm F, Krüwel T, Solecki G, Hahn A, Wirthschaft P, Berghoff AS, Haas M, Venkataramani V, von Deimling A, Wick W, Herold-Mende C, Heiland S, Platten M, Bendszus M, Kurz FT, Winkler F, Tews B.

Front Neurosci. 2019 Jan 10;12:1004. doi: 10.3389/fnins.2018.01004. eCollection 2018.

35.

Temporal evolution of acute multiple sclerosis lesions on serial sodium (23Na) MRI.

Eisele P, Konstandin S, Szabo K, Ebert A, Roßmanith C, Paschke N, Kerschensteiner M, Platten M, Schoenberg SO, Schad LR, Gass A.

Mult Scler Relat Disord. 2019 Apr;29:48-54. doi: 10.1016/j.msard.2019.01.027. Epub 2019 Jan 17.

PMID:
30669020
36.

Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosis.

Eisele P, Szabo K, Ebert A, Radbruch A, Platten M, Schoenberg SO, Gass A.

Magn Reson Imaging. 2019 May;58:1-5. doi: 10.1016/j.mri.2019.01.007. Epub 2019 Jan 7.

PMID:
30630068
37.

MRI of Iron Oxide Nanoparticles and Myeloperoxidase Activity Links Inflammation to Brain Edema in Experimental Cerebral Malaria.

Hoffmann A, Pfeil J, Mueller AK, Jin J, Deumelandt K, Helluy X, Wang C, Heiland S, Platten M, Chen JW, Bendszus M, Breckwoldt MO.

Radiology. 2019 Feb;290(2):359-367. doi: 10.1148/radiol.2018181051. Epub 2018 Dec 4.

PMID:
30615566
38.

Actively personalized vaccination trial for newly diagnosed glioblastoma.

Hilf N, Kuttruff-Coqui S, Frenzel K, Bukur V, Stevanović S, Gouttefangeas C, Platten M, Tabatabai G, Dutoit V, van der Burg SH, Thor Straten P, Martínez-Ricarte F, Ponsati B, Okada H, Lassen U, Admon A, Ottensmeier CH, Ulges A, Kreiter S, von Deimling A, Skardelly M, Migliorini D, Kroep JR, Idorn M, Rodon J, Piró J, Poulsen HS, Shraibman B, McCann K, Mendrzyk R, Löwer M, Stieglbauer M, Britten CM, Capper D, Welters MJP, Sahuquillo J, Kiesel K, Derhovanessian E, Rusch E, Bunse L, Song C, Heesch S, Wagner C, Kemmer-Brück A, Ludwig J, Castle JC, Schoor O, Tadmor AD, Green E, Fritsche J, Meyer M, Pawlowski N, Dorner S, Hoffgaard F, Rössler B, Maurer D, Weinschenk T, Reinhardt C, Huber C, Rammensee HG, Singh-Jasuja H, Sahin U, Dietrich PY, Wick W.

Nature. 2019 Jan;565(7738):240-245. doi: 10.1038/s41586-018-0810-y. Epub 2018 Dec 19. Erratum in: Nature. 2019 Feb;566(7745):E13.

PMID:
30568303
39.

Upregulation of tryptophanyl-tRNA synthethase adapts human cancer cells to nutritional stress caused by tryptophan degradation.

Adam I, Dewi DL, Mooiweer J, Sadik A, Mohapatra SR, Berdel B, Keil M, Sonner JK, Thedieck K, Rose AJ, Platten M, Heiland I, Trump S, Opitz CA.

Oncoimmunology. 2018 Sep 5;7(12):e1486353. doi: 10.1080/2162402X.2018.1486353. eCollection 2018.

40.

Brain Atrophy in Natalizumab-treated Patients with Multiple Sclerosis: A 5-year Retrospective Study.

Eisele P, Szabo K, Ebert A, Platten M, Gass A.

J Neuroimaging. 2019 Mar;29(2):190-192. doi: 10.1111/jon.12586. Epub 2018 Nov 28.

PMID:
30485572
41.

Acute Corticonuclear Tract Ischemic Stroke with Isolated Central Facial Palsy.

Wolf ME, Rausch HW, Eisele P, Habich S, Platten M, Alonso A.

J Stroke Cerebrovasc Dis. 2019 Feb;28(2):495-498. doi: 10.1016/j.jstrokecerebrovasdis.2018.10.030. Epub 2018 Nov 13.

PMID:
30446207
42.

Antiretroviral treatment indications and adherence to the German-Austrian treatment initiation guidelines in the German ClinSurv HIV Cohort between 1999 and 2016.

Stecher M, Schommers P, Schmidt D, Kollan C, Gunsenheimer-Bartmeyer B, Lehmann C, Platten M, Fätkenheuer G, Vehreschild JJ; ClinSurv Study Group.

Infection. 2019 Apr;47(2):247-255. doi: 10.1007/s15010-018-1248-8. Epub 2018 Nov 9. Erratum in: Infection. 2019 Feb 25;:.

PMID:
30414065
43.

N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma.

Wick W, Dettmer S, Berberich A, Kessler T, Karapanagiotou-Schenkel I, Wick A, Winkler F, Pfaff E, Brors B, Debus J, Unterberg A, Bendszus M, Herold-Mende C, Eisenmenger A, von Deimling A, Jones DTW, Pfister SM, Sahm F, Platten M.

Neuro Oncol. 2019 Jan 1;21(1):95-105. doi: 10.1093/neuonc/noy161.

44.

Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib.

Berberich A, Kessler T, Thomé CM, Pusch S, Hielscher T, Sahm F, Oezen I, Schmitt LM, Ciprut S, Hucke N, Ruebmann P, Fischer M, Lemke D, Breckwoldt MO, von Deimling A, Bendszus M, Platten M, Wick W.

Clin Cancer Res. 2019 Jan 1;25(1):253-265. doi: 10.1158/1078-0432.CCR-18-1580. Epub 2018 Oct 1.

45.

T cells engineered to home in on brain cancer.

Platten M.

Nature. 2018 Sep;561(7723):319-320. doi: 10.1038/d41586-018-05883-7. No abstract available.

PMID:
30224728
46.

Perspectives of immunotherapy in isocitrate dehydrogenase-mutant gliomas.

Friedrich M, Bunse L, Wick W, Platten M.

Curr Opin Oncol. 2018 Nov;30(6):368-374. doi: 10.1097/CCO.0000000000000478. Review.

PMID:
30102604
47.

Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.

Shraibman B, Barnea E, Kadosh DM, Haimovich Y, Slobodin G, Rosner I, López-Larrea C, Hilf N, Kuttruff S, Song C, Britten C, Castle J, Kreiter S, Frenzel K, Tatagiba M, Tabatabai G, Dietrich PY, Dutoit V, Wick W, Platten M, Winkler F, von Deimling A, Kroep J, Sahuquillo J, Martinez-Ricarte F, Rodon J, Lassen U, Ottensmeier C, van der Burg SH, Thor Straten P, Poulsen HS, Ponsati B, Okada H, Rammensee HG, Sahin U, Singh H, Admon A.

Mol Cell Proteomics. 2018 Nov;17(11):2132-2145. doi: 10.1074/mcp.RA118.000792. Epub 2018 Aug 2. Retraction in: Mol Cell Proteomics. 2019 Jun;18(6):1270.

48.

Understanding and Treating Glioblastoma.

Wick W, Platten M.

Neurol Clin. 2018 Aug;36(3):485-499. doi: 10.1016/j.ncl.2018.04.006. Review.

PMID:
30072067
49.

Nonmeasurable Speckled Contrast-Enhancing Lesions Appearing During Course of Disease Are Associated With IDH Mutation in High-Grade Astrocytoma Patients.

Berberich A, Hielscher T, Kickingereder P, Winkler F, Drüschler K, Riedemann L, Arzt M, Kessler T, Platten M, von Deimling A, Wick W, Sahm F, Bendszus M, Wick A.

Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1472-1480. doi: 10.1016/j.ijrobp.2018.07.2004. Epub 2018 Jul 31.

PMID:
30071292
50.

Short Communication: Tracking Tregs: Translocation of CD49b/LAG-3+ Type 1 T Regulatory Cells to the Gut-Associated Lymphoid Tissue of HIV+ Patients.

Augustin M, Horn C, Koch J, Sandaradura de Silva U, Platten M, Nierhoff D, Suarez I, Chon SH, Rybniker J, Lehmann C.

AIDS Res Hum Retroviruses. 2019 Mar;35(3):247-250. doi: 10.1089/AID.2018.0052. Epub 2018 Sep 11.

PMID:
30019612

Supplemental Content

Loading ...
Support Center